CAS: 502-50-1; 4-Oxoheptanedioic Acid

该化合物是一种二色箱酸,其特征是其独特的结构,包括一个氯酮功能组和两个碳箱酸组,在室温下,一种无色的黄色固体,可溶于水和各种有机溶剂,该化合物具有C7H10O5的分子配方,并具有反映其碳,氢和氧原子构成的分子重量特征.4-Ketomilic酸主要用于有机合成和作为生产各种化学化合物的中间体.其再活动受氯酮和碳箱酸组的存在的影响,使其能够参与一系列化学反应,包括酯化和凝聚.此外,该化合物在生物化学和制药领域具有潜在应用性,可以用作更复杂的分子的建筑块块.安全数据表明,与许多有机酸一样,它应作为避免刺激或不利反应的处理方式.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号3505-67-7 1,6-二氧杂螺[4.4]壬烷... | CAS号7766-83-8 dimethyl 4-nitr... | CAS号502-51-2 2-oxo-3H-furan-... | CAS号6317-49-3 4-氧代庚二酸二乙酯 | CAS号99-32-1 白屈菜酸 | CAS号110-15-6 琥珀酸; 丁二酸 | CAS号58940-07-1 1-(4-Methyl-3-p... | CAS号10034-85-2 氢碘酸 | CAS号7647-01-0 盐酸 | CAS号112599-91-4 1,1'-dimethyl-d... | CAS号6317-49-3 4-氧代庚二酸二乙酯 | CAS号1506-55-4 3-氧代戊烷-1,5-二羧酸单乙酯 | CAS号18356-28-0 Rolziracetam | CAS号7766-86-1 3-(5-氧代-吡咯烷-2-基)-丙酸 | CAS号111-16-0 庚二酸 | CAS号3505-67-7 1,6-二氧杂螺[4.4]壬烷... | CAS号69186-21-6 5-(3-hydroxypro... | CAS号98334-84-0 3-(6-oxo-1,4,5,... | CAS号22634-92-0 Heptanedioic ac...

合成工艺路线路线简述

    📜2-呋喃丙烯酸置于硫酸体系中,用 水 作为反应溶剂,化学反应 24.0H,反应生成 4-酮庚二酸
    参考文献:硫酸和amberlyst-H +催化可再生酮酸与低聚甲醛的缩合反应:合成新的双螺双内酯环系统2,9,13-三恶二螺[4.1.4.3]十四烷-3,6,10-三酮†
    标题:硫酸和amberlyst-H +催化可再生酮酸与低聚甲醛的缩合反应:合成新的双螺双内酯环系统2,9,13-三恶二螺[4.1.4.3]十四烷-3,6,10-三酮†
    摘要:硫酸和amberlyst-H +催化的可再生原料乙酰丙酸与多聚甲醛在80oc的纯净条件下的缩合反应,在91-中得到2,9,11,14-四恶二螺[4.1.5.3] Pentadecane-3,6-Dione收率93%,其中通过单晶x射线晶体学确认了结构.4-酮庚二酸和低聚甲醛在80oc的类似缩合反应可得到2,9,13-三恶二螺[4.1.4.3]十四烷-3,6,10-三酮.发现这种新的双螺双内酯由具有对称平面的异构体的1.6∶1混合物组成,该对称平面将四氢-2 H-吡喃-4-酮环通过羰基二等分.
    DOI:10.1039/c7Ra02303K

    海关参考信息

    专利信息


    专利号:US-9920084-B2
    优先权日:2011-08-23
    标题 :Ionic tags for synthesis of oligoribonucleotides
    发明人:DAMHA MASAD J; HASSLER MATTHEW; CHAN TAK-HANG; NANDYALA MALLIKARJUNA REDDY; DONGA ROBERT ALEXANDER
    权利人:DAMHA MASAD J; HASSLER MATTHEW; CHAN TAK HANG; NANDYALA MALLIKARJUNA REDDY; DONGA ROBERT ALEXANDER; THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIV; HONG KONG POLYTECHNIC UNIV
    摘要:The invention relates to the chemical synthesis of oligonucleotides, e.g., oligoribonucleotides. In another aspect, the invention relates to compounds of formula (II) processes for making these compounds, and the use thereof in the chemical synthesis of oligonucleotides, e.g., oligoribonucleotides. The invention also relates to methods of synthesis of oligomers, including but not limited to oligopeptides, oligosaccharides and oligonucleotides, particularly oligoribonucleotides and also oligodeoxyribonucleotides, in solution systems, and ionic tag linkers for use in methods provided herein.

    专利号:US-2009111737-A1
    优先权日:1999-05-24
    标题:Novel antibacterial agents
    发明人:CHRISTENSEN BURTON G; MORAN EDMUND J; GRIFFIN JOHN H; JUDICE J KEVIN; MU YONGQI; PACE JOHN L; MAMMEN MATHAI; AGGEN JAMES
    权利人:CHRISTENSEN BURTON G; MORAN EDMUND J; GRIFFIN JOHN H; JUDICE J KEVIN; MU YONGQI; PACE JOHN L; MAMMEN MATHAI; AGGEN JAMES
    摘要:This invention relates to novel multibinding compounds (agents) that are antibacterial agents. The multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands in their monovalent (i.e., unlinked) state have the ability to bind to a an enzyme involved in cell wall biosynthesis and metabolism, a precursor used in the synthesis of the bacterial cell wall and/or the bacterial cell surface thereby interfere with the synthesis and/or metabolism of the cell wall. In particular the multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands hasn a ligand domain capable of binding to penicillin binding proteins, a transpeptidase enzyme, a substrate of a transpeptidase enzyme, a beta-lactamase enzyme, pencillinase enzyme, cephalosporinase enzyme, a transglycoslase enzyme, or a transglycosylase enzyme substrate; Preferably, the ligands are selected from the beta lactam or glycopeptide class of antibacterial agents.

    专利号:US-2005282781-A1
    优先权日:2004-06-18
    标 题 :Compositions of stable bioactive metabolites of docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids
    发明人:GHOSAL SHIBNATH
    权利人:GHOSAL SHIBNATH
    摘要:An invention that adduces cogent evidence to establish that oxygenated dibenzo-α-pyrones (DBPs and their conjugates), the major bioactives of shilajit (Ayurvedic vitalizer), have their origin, at least partly, in EPA and DHA. Earlier research has shown that, in mammals, C-20 PUFAs are metabolized by oxygenases and other enzymes to produce short-lived prostaglandins, leukotrienes and thromboxanes that bind to specific G-protein-coupled receptors and signal cellular responses, e.g., inflammation, vasodilation, blood pressure, pain etc. But never before it was suggested/shown that C 20:5n-3 (and C 22:6 n-3 ) PUFAs, e.g., EPA (and DHA), are transformed into stable aromatic metabolites, DBPs, which elicit a large array of bioactivities in the producer organisms and also control the synthesis and metabolism of arachidonate-derived prostaglandins. The major beneficial effects attributed to EPA and DHA are now found to be largely contributed by DBPs and their aminoacyl conjugates and the dibenzo-α-pyrone-chromoproteins (DCPs). Because of the highly unstable nature of EPA and DHA, when administered, they are metabolized into a large array of uncontrolled products, several of which are systemically undesirable. By contrast, DBPs, because of their stability, perform the biological response modifier (BRM) functions in a directed and sustained way. Many of the biological effects of DBPs described in this invention, were earlier attributed to EPA and DHA,—the precursors of DBPs.

    专利号:US-8653223-B2
    优先权日:2008-04-16
    标题:Transketalized compositions, synthesis, and applications
    发明人:SELIFONOV SERGEY; GOETZ ADAM EDWARD; JING FENG
    权利人:SELIFONOV SERGEY; GOETZ ADAM EDWARD; JING FENG; SEGETIS INC
    摘要:Ketal compounds of the structure I n nand a method of preparation of the compound from polyols and oxocarboxylates, as well as uses thereof.

    专利号:US-2005009151-A1
    优先权日:2003-07-10
    标 题 :Methods for the stereospecific and enantiomeric enrichment of beta-amino acids
    发明人:CHASE MATTHEW; CLAYTON ROBERT; LANDIS BRYAN; BANERJEE AMIT
    权利人:PHARMACIA CORP
    摘要:The present invention relates to methods for the stereospecific synthesis and for the enantiomeric enrichment of β-amino acids. A novel D-β-aminotransferase, which exhibits stereoselectivity for D-β-phenylalanine, (D-3 amino-3-phenylpropinine acid) was purified from a newly-isolated strain of Variouorax paradoxus . A novel L-β-aminotransferase was purified from a newly-isolated strain of Alcaligenes eutrophus . The D- and L-β-aminotransferases can be used to facilitate the stereoselective biosynthesis of β-D-phenylalanine or β-L-phenylalanine, from a mixture of L-glutamic acid or L-alanine, respectively, and 3-keto-3-phenylpropionic acid in the presence of the cofactor pyridoxal phosphate.

    专利号:US-8546519-B2
    优先权日:2007-10-09
    标题 :Polyketal compounds, synthesis, and applications
    发明人:SELIFONOV SERGEY; ROTHSTEIN SCOTT D; WICKS DOUGLAS A; MULLEN BRIAN D; MULLEN TARA J; PRATT JASON D; WILLIAMS CHARLES T; WU CHUNYONG; ZHOU NING
    权利人:SELIFONOV SERGEY; ROTHSTEIN SCOTT D; WICKS DOUGLAS A; MULLEN BRIAN D; MULLEN TARA J; PRATT JASON D; WILLIAMS CHARLES T; WU CHUNYONG; ZHOU NING; SEGETIS INC
    摘要:The invention relates to polyketal compounds. The compounds are synthesized by the selective ketalization of oxocarboxylic acids, e.g. keto acids and semialdehydes, and esters thereof with tetrols and higher polyols that products two or more cyclic ketal ester moieties per molecule, wherein the cyclic ketal moieties are situated in a bis-, tris-, or polyketal conformation. The invention further relates to applications of these compounds and subsequent reactions thereof.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Smith, L. H. S.; Coote, S. C.; Procter, D. J., Science of Synthesis Knowledge Updates, (2010) 3, 481.
    摘要:Pohl, M.; Wechsler, C.; Müller, M., Science of Synthesis: Biocatalysis in Organic Synthesis, (2015) 2, 123.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知